Insurance industry officials want the CMS to give them a leading role in any pilot progams allowing the feds to pay for housing and similar social needs of patients.
As the year comes to a close, CHI-Dignity are poised to create a mega health system. Meanwhile, in D.C., budget drama unfolds like a reality T.V. show.
The CMS didn't risk-stratify hospitals by peer groups based on their dual-eligible population as it currently does in the Hospital Readmissions Reduction Program. That can earn hospitals low ratings for caring for poor and chronically ill patients.
The White House gathered a group of interoperability boosters for its forum on healthcare data interoperability, where the CMS and others pushed for greater data exchange, including for patients.
The CMS will update star ratings for Hospital Compare in February after a 14-month delay to resolve issues with the model, but the agency did not address some of critics' biggest concerns.
About 55% of hospitals earned Medicare incentive payments in 2019 under the Hospital Value-based Purchasing Program, slightly fewer than in fiscal 2018 when 57% of the hospitals did, or just under 1,600.
NQF's Measure Applications Partnership has 39 measures to consider. The CMS said it chose the measures based on its Meaningful Measures framework.
A government watchdog warned that Medicare could end up spending more money on laboratory tests, even though the CMS has reformed its payment system.
The agency released a draft strategy outlining how vendors, providers and federal agencies can reduce the technology-related burden on clinicians, including by simplifying EHR reporting requirements.
Of the 14,959 skilled-nursing facilities subject to the CMS' Skilled Nursing Facility Value-based Purchasing Program, 73% received a penalty while 27% got a bonus for fiscal 2019.
In a sweeping new proposal focused on Medicare Advantage and Medicare Part D, the CMS is considering a policy to cut off pharmacy profits through price concessions and give Medicare Part D plans more power to negotiate protected class drug prices.
The CMS gave the green light to Michigan Medicaid's outcome-based drug proposal, the second of its kind. Oklahoma has yet to forecast savings from its similar state plan amendment approved in June.